Urinary complement factor H in renal disease

Nephron. 2002;92(3):705-7. doi: 10.1159/000064090.

Abstract

Background: Complement factor H (hCFH) plays a key inhibitory role in the control of the alternative complement pathway. We examined whether urinary hCFH (U-hCFH) levels is useful as an indirect indicator of renal damage.

Methods: Urine samples were obtained from 104 patients with renal disease. Urine was collected with 10 mM EDTA and U-hCFH levels were measured using the BTA TRAK Assay Kit.

Results: In the 62 patients with nephritis, the levels of U-hCFH were elevated (range 15-52,198 U/ml) over the normal range (0-14 U/ml). U-hCFH levels of patients with chronic renal failure, lupus nephritis, membranoproliferative glomerulonephritis, focal glomerulosclerosis were higher than that of IgA nephropathy patients (p < 0.05). In the patients with minimal change disease, showed high levels of U-hCFH during the nephrotic syndrome. U-hCFH was correlated significantly with urinary protein and urinary N-acetyl-beta-D-glucosaminidase.

Conclusions: We demonstrated that U-hCFH was detected in the urine of nephritis patients.

MeSH terms

  • Biomarkers
  • Complement Activation
  • Complement Factor H / urine*
  • Female
  • Glomerulonephritis, Membranoproliferative / urine*
  • Humans
  • Lupus Nephritis / urine
  • Male
  • Middle Aged
  • Nephritis, Interstitial / urine
  • Nephrosis, Lipoid / urine

Substances

  • Biomarkers
  • CFH protein, human
  • Complement Factor H